You are here: All Products  > GenFleet to Receive Royalty Rights for Conducting China Trial of BioLineRx Cancer Drug

GenFleet to Receive Royalty Rights for Conducting China Trial of BioLineRx Cancer Drug

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.